Showing results (61-70 of 302) with videos related to
Sort By:
Pageof 31
European Journal of Cancer (Oxford, England : 1990)|February 20, 2017
Ipilimumab alone or in combination with nivolumab after progression on anti-PD-1 therapy in advanced melanomaLisa Zimmer, Susmitha Apuri, Zeynep Eroglu, et al.Targeted Oncology|February 8, 2021
Serum S100B and LDH at Baseline and During Therapy Predict the Outcome of Metastatic Melanoma Patients Treated with BRAF InhibitorsMaximilian Gassenmaier, Max M Lenders, Andrea Forschner, et al.European Journal of Nuclear Medicine and Molecular Imaging|August 24, 2017
18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy startFerdinand Seith, Andrea Forschner, Holger Schmidt, et al.Diagnostics (Basel, Switzerland)|August 10, 2024
An Automated Real-Time PCR Assay versus Next-Generation Sequencing in the Detection of BRAF V600 Mutations in Melanoma Tissue SamplesDaniela Lenders, Irina Bonzheim, Matthias Hahn, et al.Oncotargets and Therapy|June 26, 2020
Circulating Tumor DNA Correlates with Outcome in Metastatic Melanoma Treated by BRAF and MEK Inhibitors - Results of a Prospective Biomarker StudyAndrea Forschner, Stephanie Weißgraeber, Dirk Hadaschik, et al.Acta Radiologica (Stockholm, Sweden : 1987)|May 26, 2021
Efficacy and tolerability of chemosaturation in patients with hepatic metastases from uveal melanomaArne Estler, Christoph Artzner, Michael Bitzer, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Influence of 18F-FDG PET/CT on clinical management and outcome in patients with advanced melanoma not primarily selected for surgery based on a linked evidence approachSusann-Cathrin Olthof, Andrea Forschner, Peter Martus, et al.Oncotarget|April 19, 2017
Human melanoma cells resistant to MAPK inhibitors can be effectively targeted by inhibition of the p90 ribosomal S6 kinaseCorinna Kosnopfel, Tobias Sinnberg, Birgit Sauer, et al.Journal of the American Academy of Dermatology|April 25, 2009
Significant response after treatment with the mTOR inhibitor sirolimus in combination with carboplatin and paclitaxel in metastatic melanoma patientsFriedegund Meier, Emmanuella Guenova, Stephan Clasen, et al.Cancers|June 2, 2021
Factors Influencing the Adjuvant Therapy Decision: Results of a Real-World Multicenter Data Analysis of 904 Melanoma PatientsGeorg Lodde, Andrea Forschner, Jessica Hassel, et al.Pageof 31